Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.7.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Assets    
Financing receivables $ 1,140,441 $ 1,042,237
Investments 126,329 58,058
Real estate 298,145 172,257
Equity method investments 550,986 363,297
Cash and cash equivalents 41,696 29,428
Other assets 130,934 80,610
Total Assets 2,288,531 1,745,887
Liabilities:    
Accounts payable, accrued expenses and other 37,559 25,219
Deferred funding obligations 273,447 170,892
Credit facilities 392,482 283,346
Nonrecourse debt (secured by assets of $1,269 million and $864 million, respectively) 921,780 692,091
Total Liabilities 1,625,268 1,171,548
Stockholders' Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 51,655,406 and 46,493,155 shares issued and outstanding, respectively 517 465
Additional paid in capital 766,894 663,744
Accumulated deficit (107,263) (92,213)
Accumulated other comprehensive income (loss) (575) (1,388)
Non-controlling interest 3,690 3,731
Total Stockholders' Equity 663,263 574,339
Total Liabilities and Stockholders' Equity $ 2,288,531 $ 1,745,887